An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.
Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some patients taking weight-loss drugs lose muscle at far faster rates than those ...
Online pharmacies will now have to employ stricter checks to stop people who are already a healthy weight or have a history ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...
Weight loss injections are prescription medications to help with weight loss. They can help alter a person’s appetite and metabolism, curbing hunger and reducing calorie intake. Weight loss ...
Weight-loss drugs have also now been added to the list of “high-risk” medicines requiring extra safeguards. If pharmacists do ...
Amid growing concern of the overuse and misuse of obesity drugs, the UK’s pharmacies regulator rolled out stricter guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results